Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 25, 2016 16:05 ET | Source: Algobate AG

Algobate Announces Positive Pre-Phase 3 Meeting With FDA for Naloxone PRT in Opioid Induced Constipation

-- Company Preparing to Initiate Phase 3 Program in 2016 -- -- Naloxone PRT Uniquely Targets the Cause of OIC in the Gastrointestinal Tract; Minimizes Undesirable Systemic Adverse Effects -- ...